Biochemical markers, Lungs -- Cancer -- Mathematical models, Lungs -- Cancer -- Patients, Neural networks (Computer science), Regression analysis
We attempted a mathematical model for expected prognosis of lung cancer patients based on a multivariate analysis of the values of ER-interacting proteins (ERbeta) and a membrane bound, glycosylated phosphoprotein MUC1), and patients clinical data recorded at the time of initial surgery. We demonstrate that, even with the limited sample size available to use, combination of clinical and biochemical data (in particular, associated with ERbeta and MUC1) allows to predict survival of lung cancer patients with about 80% accuracy while prediction on the basis of clinical data only gives about 70% accuracy. The present work can be viewed as a pilot study on the subject: since results confirm that ER-interacting proteins indeed influence lung cancer patients’ survival, more data is currently being collected.
If this is your thesis or dissertation, and want to learn how to access it or for more information about readership statistics, contact us at STARS@ucf.edu
Master of Science (M.S.)
College of Sciences
Length of Campus-only Access
Masters Thesis (Open Access)
Dissertations, Academic -- Sciences, Sciences -- Dissertations, Academic
Martinenko, Evgeny, "Prediction Of Survival Of Early Stages Lung Cancer Patients Based On Er Beta Cellular Expressions And Epidemiological Data" (2011). Electronic Theses and Dissertations. 1767.